Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$49.00
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Omnicare Inc gives FY 2014 guidance; EPS guidance below analysts' estimates - Conference Call


Thursday, 20 Feb 2014 12:00pm EST 

Omnicare Inc:Sees FY 2014 net sales between $6.3 billion and $6.4 billion.Sees FY 2014 Adjusted cash earnings per diluted share to be $3.64 to $3.72.FY 2014 revenues of $6.3 billion and EPS of $3.75 - Thomson Reuters I/B/E/S Estimates. 

Company Quote

76.74
-0.07 -0.09%
27 Feb 2015